All quantification methods were detailed in our previous study21 (link). Briefly, the QPLEXTM kit utilized Quantamatrix’s multiplex diagnostics platform (QMAP; Quantamatrix Inc., Seoul, Republic of Korea)29 . First, human plasma samples (singular) were diluted in diluent buffer and incubated with the coded beads and biotin-conjugated detection antibodies (angiotensin-converting enzyme, ACE, DY929, R&D Systems, Minneapolis, USA; galectin-3 binding protein, LGALS3BP, DY2226, R&D Systems; periostin, POSTN, DY3548B, R&D Systems; Aβ1−40, 014-26923, Wako, Japan). The immunocomplexes were washed twice with washing buffer at a Biotek-510 magnetic wash station (Biotek, VT, USA). Diluted R-phycoerythrin-conjugated streptavidin was added to each well. After three washes, the immunocomplexes were resuspended in 100 μl of washing buffer by tapping and automatically analyzed using the QMAPTM system. The intra/interassay coefficients of variation and limits of detection were as follows: ACE, intra: 4.9%, inter: 5.1%, 0.22 ng/ml; LGALS3BP, intra: 1.1%, inter: 5.7%, 0.04 ng/ml; POSTN, intra: 9.0%, inter: 6.0%, 0.034 ng/ml; and Aβ1−40, intra: 5.3%, inter: 3.9%, 0.50 pM.
Free full text: Click here